88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"? BEIJING , Aug. 21, 2026 /PRNewswire/ -- Personalized mRNA cancer therapy has recently reached an important milestone. An international Phase 3 study in high-risk melanoma reported positive results, ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy NANJING, China , Aug. 21, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the Center for Drug Evaluation ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Colgate-Palmolive elevates Prabha Narasimhan to EVP - Marketing, Asia-Pacific MUMBAI, India , Aug. 21, 2026 /PRNewswire/ -- Prabha Narasimhan, Managing Director and Chief Executive Officer of Colgate-Palmolive (India) Limited has been elevated to the role of Executive Vice President ... 2026-08-21T Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026 SHANGHAI , Aug. 21, 2026 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth SHANGHAI , Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, representing ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
/C O R R E C T I O N -- Akeso, Inc./ In the news release, Akeso's AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline, issued 21-Aug-2026 by Akeso, Inc. over PR Newswire, we are ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Sunshine Guojian Releases 2026 Interim Report: Innovation-driven, Steady Advancement ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Angel Yeast's AHH Packaging Design Recognized with Red Dot Award SHANGHAI , Aug. 20, 2026 /PRNewswire/ -- Angel Nutritech, a professional yeast biotechnology subsidiary under Angel Yeast (SSE: 600298), has been recognized for its Angel Human Health (AHH) yeast essence ... 2026-08-21T Biotechnology Food/Beverages Health Care/Hospital
inFlow Inventory launches lot number and expiry date tracking Small manufacturers and distributors in food, beverage, pharmaceutical and medical device industries can now trace any batch from receipt to customer, at a fraction of the cost of an enterprise ERP. ... 2026-08-20T Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved